Figure S12 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer

<p>Experiments related to the assessment of the therapeutic potential of R162/MYLK-AS1 ASO in TKI resistance.</p>

Authors

Lei Song
Xiyi Lu
Tianyu Qu (ORCID: https://orcid.org/0000-0002-4242-0615)
Chen Zhang
Erbao Zhang (ORCID: https://orcid.org/0000-0002-5752-7976)
Dandan Yin (ORCID: https://orcid.org/0000-0002-2550-5254)
Jiali Dai (ORCID: https://orcid.org/0000-0002-4533-9185)
Renhua Guo
Jiali Xu (ORCID: https://orcid.org/0009-0001-2645-7223)

Publication Details

Published: 2025-08-15
DOI: https://doi.org/10.1158/0008-5472.29919060
Primary Topic: Lung Cancer Treatments and Mutations
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Figure S12 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer

Lei Song, Xiyi Lu, Tianyu Qu, Chen Zhang et al.

Aug 15, 2025

Lung Cancer Treatments and Mutations

article

Figure S12 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer

Lei Song, Xiyi Lu, Tianyu Qu, Chen Zhang, Erbao Zhang, Dandan Yin, Jiali Dai, Renhua Guo, Jiali Xu

August 15, 2025article en

Abstract

<p>Experiments related to the assessment of the therapeutic potential of R162/MYLK-AS1 ASO in TKI resistance.</p>

Good health and well-being

Openalex Percentile: Top 67%

Lung Cancer Treatments and Mutations

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Figure S12 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer — Lei Song, Xiyi Lu, et al. · (2025) | TGRS Research Map | TGRS